trending Market Intelligence /marketintelligence/en/news-insights/trending/tPupTwkRkbKGgXg9ZhssZQ2 content esgSubNav
In This List

Concert Pharmaceuticals CFO to quit

Blog

Technology & Automation Insights: Elevating KYC and onboarding efficiency

Blog

Data Insights: Enhancing regulatory compliance and client lifecycle management.

Blog

Banking Essentials Newsletter: 17th April Edition

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Concert Pharmaceuticals CFO to quit

Concert Pharmaceuticals Inc. CFO Ryan Daws will leave the company in June to join Baird as its managing director of life sciences and biotech.

Daws will continue to consult with Concert and help the company close the sale of its investigational cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals Inc.

The company said it has initiated a search for a new CFO.